Viewing Study NCT00416533


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-02-01 @ 4:00 PM
Study NCT ID: NCT00416533
Status: COMPLETED
Last Update Posted: 2017-01-19
First Post: 2006-12-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Sponsor: Wake Forest University Health Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent prostate cancer View
None stage III prostate cancer View
None stage IV prostate cancer View
None adenocarcinoma of the prostate View